Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.181.491.371.031.28

What is the latest Working Capital/Sales ratio of BLISS GVS PHARMA ?

The latest Working Capital/Sales ratio of BLISS GVS PHARMA is 1.18 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.18
Mar20231.49
Mar20221.37
Mar20211.03
Mar20201.28

How is Working Capital/Sales of BLISS GVS PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.18
-20.81
Mar2023 1.49
8.76
Mar2022 1.37
33.01
Mar2021 1.03
-19.53
Mar2020 1.28 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Working Capital/Sales ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,316.4 Cr 7.3% 9% 10.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,390.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

7.3%

9%

10.2%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses